Multidisciplinary approaches to coping with neurodegenerative disorders amid COVID-19 pandemic

Q3 Biochemistry, Genetics and Molecular Biology
Hannan, R. Dash, B. Timalsina, Y. A. Munni, Sarmistha Mitra, D. F. Oktaviani, Haque, A. Sohag, M. D. N. Meinita, I. Moon
{"title":"Multidisciplinary approaches to coping with neurodegenerative disorders amid COVID-19 pandemic","authors":"Hannan, R. Dash, B. Timalsina, Y. A. Munni, Sarmistha Mitra, D. F. Oktaviani, Haque, A. Sohag, M. D. N. Meinita, I. Moon","doi":"10.5455/jabet.2022.d100","DOIUrl":null,"url":null,"abstract":"Neurodegenerative disorders, including Alzheimer’s and Parkinson’s, are the leading causes of dementia in the elderly. In the coming days, an alarming upsurge of dementia patients is expected with increasing life expectancy. This is the scenario not only in the developed world but also in the developing world, where older people live in vulnerable situations. Even in the COVID-19 (coronavirus disease-19) pandemic, the situation has worsened. Due to the limitations of conventional therapeutic strategies, it is necessary to explore integrated approaches consisting of both pharmacological and non-pharmaceutical interventions. As existing anti-dementia drugs pose many adverse effects on patients, pharmacological intervention through naturally occurring agents should be employed to explore targeted therapy. Alongside, non-pharmacological interventions such as cognitive and motor rehabilitation, occupational therapy, and psychological therapy need to be explored. From this perspective, multidisciplinary approaches need to be employed in order to develop a sustainable patient-friendly treatment strategy for the management of these emerging health issues with tremendous social burdens. © 2022, Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology. All rights reserved.","PeriodicalId":36275,"journal":{"name":"Journal of Advanced Biotechnology and Experimental Therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Biotechnology and Experimental Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/jabet.2022.d100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Neurodegenerative disorders, including Alzheimer’s and Parkinson’s, are the leading causes of dementia in the elderly. In the coming days, an alarming upsurge of dementia patients is expected with increasing life expectancy. This is the scenario not only in the developed world but also in the developing world, where older people live in vulnerable situations. Even in the COVID-19 (coronavirus disease-19) pandemic, the situation has worsened. Due to the limitations of conventional therapeutic strategies, it is necessary to explore integrated approaches consisting of both pharmacological and non-pharmaceutical interventions. As existing anti-dementia drugs pose many adverse effects on patients, pharmacological intervention through naturally occurring agents should be employed to explore targeted therapy. Alongside, non-pharmacological interventions such as cognitive and motor rehabilitation, occupational therapy, and psychological therapy need to be explored. From this perspective, multidisciplinary approaches need to be employed in order to develop a sustainable patient-friendly treatment strategy for the management of these emerging health issues with tremendous social burdens. © 2022, Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology. All rights reserved.
应对COVID-19大流行期间神经退行性疾病的多学科方法
神经退行性疾病,包括阿尔茨海默病和帕金森病,是老年人痴呆症的主要原因。在未来的日子里,随着预期寿命的延长,预计痴呆症患者将出现惊人的增长。这种情况不仅发生在发达国家,也发生在发展中国家,那里的老年人生活在脆弱的环境中。即使在COVID-19(冠状病毒病-19)大流行中,情况也有所恶化。由于传统治疗策略的局限性,有必要探索包括药理学和非药物干预的综合方法。由于现有抗痴呆药物对患者存在诸多不良反应,应采用天然药物进行药物干预,探索靶向治疗。此外,非药物干预,如认知和运动康复,职业治疗和心理治疗需要探索。从这个角度来看,需要采用多学科方法,以便为管理这些具有巨大社会负担的新出现的健康问题制定一种可持续的病人友好治疗战略。©2022,孟加拉国微生物学、免疫学和先进生物技术学会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Advanced Biotechnology and Experimental Therapeutics
Journal of Advanced Biotechnology and Experimental Therapeutics Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
1.90
自引率
0.00%
发文量
41
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信